Medicon Valley Alliance Newshttp://www.mva.orgMVA Newsen-usmva@mva.orgNews Section is Closed During Julyhttp://www.mva.org/composite-3832.htm 2009-07-01T00:00:003832MVA Newsletter, June 2009http://www.mva.org/composite-3831.htm 2009-07-01T00:00:003831Clinical Trials Update: Active Biotech and Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trialhttp://www.mva.org/composite-3327.htm 2009-06-30T00:00:003327Call for Proposals for 2011 ESF Research Conferenceshttp://www.mva.org/composite-3827.htm 2009-06-30T00:00:003827The Baltic Sea Region to Strengthen Smart Growthhttp://www.mva.org/composite-3826.htm 2009-06-29T00:00:003826People on the Move: Four Scientists from DTU Receive DKK 14,3 Mio. (in Danish)http://www.mva.org/composite-3117.htm 2009-06-26T00:00:003117Hansa Medical and Inverness Medical Innovations begin a Partnership Agreement (in Swedish)http://www.mva.org/composite-3821.htm 2009-06-22T00:00:003821LU Bioscience Invests in Novel Anti-Cancer Treatment Companyhttp://www.mva.org/composite-3815.htm 2009-06-19T00:00:003815Two of the Largest European Intellectuel Property Law Firms, Albihns and Zacco, Mergehttp://www.mva.org/composite-3814.htm 2009-06-18T00:00:003814Hansa Medical and Axis-Shield Enter Agreement on New Biomarker (in Swedish)http://www.mva.org/composite-3810.htm 2009-06-16T00:00:003810The Novo Nordisk Foundation Center for Protein Research Is Now Openhttp://www.mva.org/composite-3809.htm 2009-06-10T00:00:003809Novo Nordisk: The Lancet Publishes Direct Comparison Study Between Liraglutide And Exenatidehttp://www.mva.org/composite-3804.htm 2009-06-09T00:00:003804DTU Nanotech Receives DKK 28 Million in Donation (in Danish)http://www.mva.org/composite-3802.htm 2009-06-04T00:00:003802Rapidus Analysis of the Decision on ESS: Now the Work Begins (in Swedish)http://www.mva.org/composite-3801.htm 2009-06-03T00:00:003801High Spirit & Tough Competition at Medicon Valley Golf Championship 2009http://www.mva.org/composite-3820.htm 2009-06-02T00:00:003820New Alarm Device for Kidney Failure Patients Nominated for Prestigious Design Awardhttp://www.mva.org/composite-3800.htm 2009-06-02T00:00:003800BREAKTHROUGH: Clear Support for the Building of ESS in Lund, Swedenhttp://www.mva.org/composite-3798.htm 2009-05-29T00:00:003798Exiqon A/S Awarded a Grant of DKK 24 Million from the Danish National Advanced Technology Foundationhttp://www.mva.org/composite-3795.htm 2009-05-28T00:00:003795CellaVision Wins SwedenBio Awardhttp://www.mva.org/composite-3796.htm 2009-05-28T00:00:003796MVA Newsletter, May 2009http://www.mva.org/composite-3791.htm 2009-05-25T00:00:003791A Great Day at Meeting Medicon Valley 2009http://www.mva.org/composite-3780.htm 2009-05-22T00:00:003780Beyond Borders 2009 - Denmark: Slut med store armbevægelser i dansk biotekhttp://www.mva.org/composite-3790.htm 2009-05-19T00:00:003790Beyond Borders 2009: Global Financial Crisis Making Biotech Business Model Unsustainablehttp://www.mva.org/composite-3783.htm 2009-05-19T00:00:003783International Diabetes Congress in Malmö: How to Prevent and Cure Diabetes (in Swedish)http://www.mva.org/composite-3782.htm 2009-05-18T00:00:003782Camurus Receives CE Mark for the Oral Mucositis Product Episilhttp://www.mva.org/composite-3779.htm 2009-05-15T00:00:003779Tough Times for the Region's Patent Agencies (in Danish)http://www.mva.org/composite-3775.htm 2009-05-14T00:00:003775The Court Supports Bavarian Nordic’s Decision to Start Patent Infringement Case Against Oxford BioMedicahttp://www.mva.org/composite-3773.htm 2009-05-13T00:00:003773DTU: Chromosome Test Can Improve Cancer Treatment (in Danish)http://www.mva.org/composite-3769.htm 2009-05-12T00:00:003769Exiqon Launches New Cancer-Test (in Danish)http://www.mva.org/composite-3768.htmMedicon Valley Life Science2009-05-12T00:00:003768Hansa Medical Granted by VINNOVA for Research Project Within Inflammatory Diseases (in Swedish)http://www.mva.org/composite-3766.htm 2009-05-08T00:00:003766ACADIA and Biovail Form Collaboration to Develop and Commercialize Pimavanserin in UShttp://www.mva.org/composite-3765.htm 2009-05-07T00:00:003765The Life Science Ambassador Programme Receives DKK 14,7 Million in Funding from Medicon Valley's Three Regionshttp://www.mva.org/composite-3781.htm 2009-05-05T00:00:003781Exiqon, Hvidovre Hospital and University of Copenhagen Collaborates on Blood Screening of Intestine Cancer (in Danish)http://www.mva.org/composite-3763.htm 2009-05-04T00:00:003763Astrazeneca Restructures the Scandinavian Organisation and Reduces Staff (in Swedish)http://www.mva.org/composite-3760.htm 2009-05-01T00:00:003760New Cooperation to Link the Region's Science Parks (in Danish)http://www.mva.org/composite-3755.htm 2009-04-30T00:00:003755Novozymes Breaks Ground for New Facility in Chinahttp://www.mva.org/composite-3756.htm 2009-04-30T00:00:003756Breakthrough: Agreement Signed on Building MAXIV in Lund (in Swedish)http://www.mva.org/composite-3753.htm 2009-04-29T00:00:003753Great Need for Joint Danish-Swedish Clinical Research Strategyhttp://www.mva.org/composite-3744.htm 2009-04-29T00:00:003744Santaris Pharma Delivers Six Cancer Target Drug Candidates to Enzon Pharmaceuticals Ahead of Schedulehttp://www.mva.org/composite-3752.htm 2009-04-29T00:00:003752Astellas Pharma AB Defy the Financial Crisis (in Swedish)http://www.mva.org/composite-3751.htm 2009-04-28T00:00:003751MVA Newsletter, April 2009http://www.mva.org/composite-3750.htm 2009-04-24T00:00:003750MVA Life Science Meeting Point at Vækstfonden's Annual Forum on 13 Mayhttp://www.mva.org/composite-3745.htm 2009-04-24T00:00:003745Novozymes and Novo Nordisk Recognized as Some of the ”World’s Most Ethical Companies” (in Danish)http://www.mva.org/composite-3748.htm 2009-04-21T00:00:003748Tigran Hands In FDA Application for Sales In the UShttp://www.mva.org/composite-3747.htm 2009-04-21T00:00:003747PROSTVAC Data Accepted for Presentation at the ASCO Annual Meetinghttp://www.mva.org/composite-3742.htm 2009-04-17T00:00:003742Bo Ahrén Elected As New Chairman of the Board of Directors at MVAhttp://www.mva.org/composite-3741.htm 2009-04-17T00:00:003741SEK 300 Million to New Venture Fund in Skåne (in Swedish)http://www.mva.org/composite-3738.htm 2009-04-14T00:00:003738FDA Advisory Committee Provides Opinion on Lundbeck's Serdolecthttp://www.mva.org/composite-3737.htm 2009-04-14T00:00:003737Danish-Swedish Governments Sign Formal Agreement on Co-hosting ESS in Scandinaviahttp://www.mva.org/composite-3733.htm 2009-04-03T00:00:003733Genzyme and Bayer HealthCare Enter New Strategic Agreementhttp://www.mva.org/composite-3730.htm 2009-04-02T00:00:003730Awapatent Once Again Sweden’s IP Firm of the Yearhttp://www.mva.org/composite-3729.htm 2009-04-02T00:00:003729SEK 250 Milllion to Research on Diabetes Complicationshttp://www.mva.org/composite-3725.htm 2009-03-30T00:00:003725Biovitrum Gets Access to Affibody Technologyhttp://www.mva.org/composite-3722.htm 2009-03-27T00:00:003722ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration on a New Class of Pro-Cognitive Schizophrenia Drugshttp://www.mva.org/composite-3721.htm 2009-03-27T00:00:003721Ideon Based Phase Holographic Imaging Attract 7 MSEKhttp://www.mva.org/composite-3720.htm 2009-03-26T00:00:003720Region Skåne and AstraZeneca Co-Create Unique Research Venture (in Swedish)http://www.mva.org/composite-3719.htm 2009-03-26T00:00:003719DTU Ranked as Best in the Nordic Countries to Collaborate with the Business Sector (in Danish)http://www.mva.org/composite-3717.htm 2009-03-24T00:00:003717Ferring Launches New Treatment of Advanced Prostate Cancer in Europehttp://www.mva.org/composite-3715.htm 2009-03-20T00:00:003715Study Shows Benefits in Discovering Second Tumor Earlyhttp://www.mva.org/composite-3714.htm 2009-03-20T00:00:003714Zealand Pharma Receives 2008 European Research & Development Awardhttp://www.mva.org/composite-3711.htm 2009-03-19T00:00:003711Euro-Diagnostica Awarded As Life Science Company of the Year by Malmö Cityhttp://www.mva.org/composite-3710.htm 2009-03-18T00:00:003710MVA Newsletter, March 2009http://www.mva.org/composite-3706.htm 2009-03-17T00:00:003706High Interest in Exclusive Meetings with Thomas Jonsson, the Medicon Valley Ambassador in Japanhttp://www.mva.org/composite-3700.htm 2009-03-17T00:00:003700Genovis Signs Distribution Agreement With Biozym Scientifichttp://www.mva.org/composite-3713.htm 2009-03-15T00:00:003713Roche and Genentech Reach a Dealhttp://www.mva.org/composite-3703.htm 2009-03-12T00:00:003703Merck and Schering-Plough to Mergehttp://www.mva.org/composite-3696.htm 2009-03-09T00:00:003696Novo Nordisk Ready to Buy Biotech Companies (in Danish)http://www.mva.org/composite-3695.htm 2009-03-09T00:00:003695Symphogen and Origen Collaborate to Produce Transgenic Chickenhttp://www.mva.org/composite-3694.htm 2009-03-06T00:00:003694University of Lund’s Diabetes Center Given the Go-Ahead for Testing Diabetes Vaccine on Infants (in Swedish)http://www.mva.org/composite-3692.htm 2009-03-05T00:00:003692New Drugs Offers the Best Treatment (in Danish)http://www.mva.org/composite-3693.htm 2009-03-05T00:00:003693TopoTarget’s Totect Recommended for Use by US Oncology Nurseshttp://www.mva.org/composite-3691.htm 2009-03-05T00:00:003691Atlas of Hereditary Diseases (in Danish)http://www.mva.org/composite-3686.htm 2009-03-04T00:00:003686Akzo Nobels Science Award to Professors at Lund University (in Swedish)http://www.mva.org/composite-3685.htm 2009-03-03T00:00:003685Mission: Placing Medicon Valley on the World Map (in Swedish)http://www.mva.org/composite-3683.htm 2009-03-02T00:00:003683Oresunddirekt Increases Attention to Business (in Danish)http://www.mva.org/composite-3680.htm 2009-03-02T00:00:003680Savene and Totect Reaches Profitability for TopoTargethttp://www.mva.org/composite-3677.htm 2009-02-27T00:00:003677New World-Class Biobank in Denmark (in Danish)http://www.mva.org/composite-3673.htm 2009-02-26T00:00:003673New Hope for Complicated Breast Cancer Treatments (in Swedish)http://www.mva.org/composite-3676.htm 2009-02-26T00:00:003676Swedish Pharmacy Market to be Liberalizedhttp://www.mva.org/composite-3672.htm 2009-02-25T00:00:003672Removing IP Bottlenecks for Commercialization of Life Science Researchhttp://www.mva.org/composite-3671.htm 2009-02-25T00:00:003671ALK and Novozymes Enter Collaborationhttp://www.mva.org/composite-3670.htm 2009-02-24T00:00:003670LiF: Introduction of New and Innovative Drugs is too Slow (in Danish)http://www.mva.org/composite-3667.htm 2009-02-20T00:00:003667Cheap Medicine for World's Poor (in Danish)http://www.mva.org/composite-3665.htm 2009-02-19T00:00:003665BioPorto Diagnostics Announces New Distributorship Agreementhttp://www.mva.org/composite-3664.htm 2009-02-19T00:00:003664MVA Newsletter, February 2009http://www.mva.org/composite-3652.htm 2009-02-18T00:00:003652Editorial, MVA Newsletter: Financial Challenges - Redefining Funding Strategieshttp://www.mva.org/composite-3645.htm 2009-02-18T00:00:003645NeuroSearch Announces Alliance with Eli Lillyhttp://www.mva.org/composite-3658.htm 2009-02-17T00:00:003658New Positions at Ideon Innovation: Mikael Kipowsky and Patrik Andersson (in Swedish)http://www.mva.org/composite-3661.htm 2009-02-17T00:00:003661MVA Welcomes Charlotte Ahlgren as New Executive Vice Presidenthttp://www.mva.org/composite-3654.htm 2009-02-17T00:00:003654Industry and Academia Co-Creating Sustainable Innovationhttp://www.mva.org/composite-3635.htm 2009-02-17T00:00:003635Idogen AB – a New Biotech Company in Medicon Valley Focusing on Autoimmune Diseases (in Danish)http://www.mva.org/composite-3633.htm 2009-02-16T00:00:003633EXINI Enters into Distribution Agreement with Al-Haya Medical Company in the Middle Easthttp://www.mva.org/composite-3639.htm 2009-02-13T00:00:003639P.U.L.S Receives a SEK 2 Million Grant from NUTEK (in Swedish)http://www.mva.org/composite-3630.htm 2009-02-12T00:00:003630Awapatent: Swedish Pessimism within R&D (in Swedish)http://www.mva.org/composite-3634.htm 2009-02-11T00:00:003634Should Denmark Invest in Swedish Research?http://www.mva.org/composite-3629.htm 2009-02-11T00:00:003629The Capital Region Launches Sundhedsprofilen (in Danish)http://www.mva.org/composite-3636.htm 2009-02-10T00:00:003636AstraZeneca Cuts Down with 15.000 Employees Globally (in Swedish)http://www.mva.org/composite-3637.htm 2009-02-09T00:00:003637Lundbeck to Acquire US-based Ovation Pharmaceuticals, Inc.http://www.mva.org/composite-3628.htm 2009-02-09T00:00:003628ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009http://www.mva.org/composite-3622.htm 2009-02-05T00:00:003622Diabetes Medicin Can Be Used as Treatment for Alzheimers (in Danish)http://www.mva.org/composite-3626.htm 2009-02-04T00:00:003626